TipRanks
Go Ultimate55% OFF

Quoin Pharmaceuticals (2EB0) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

2EB0 Analyst Ratings

Strong Buy
5Ratings
5Buy0Hold0Sell
Based on 5 analysts giving stock ratings to Quoin Pharmaceuticals in the past 3 months

2EB0 Stock 12 Month Forecast

EUR 19.10▲(394.75% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Quoin Pharmaceuticals in the last 3 months. The average price target is EUR 19.10 with a high forecast of EUR 31.23 and a low forecast of EUR 12.49. The average price target represents a 394.75% change from the last price of EUR 3.86.
Highest Price TargetEUR 31.23Average Price TargetEUR 19.10Lowest Price TargetEUR 12.49

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:2EB0
Price TargetFollowArticle
Canaccord GenuityEUR 16.06buy316.15%UpsideInitiated10/19/26
BTIGEUR 12.49buy223.67%UpsideInitiated10/12/26
Lake StreetEUR 17.85buy362.39%UpsideInitiated09/23/26
Maxim GroupEUR 14.28→EUR 17.85buy362.39%UpsideReiterated09/03/26
Alliance Global PartnersEUR 31.23buy709.17%UpsideReiterated08/17/26
ThinkEquityEUR 10.71buy177.43%UpsideInitiated06/15/26
Lucid CapitalEUR 26.77buy593.58%UpsideInitiated05/04/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ORKAOruka Therapeutics
ACHVAchieve Life Sciences
OVIDOvid Therapeutics
ZYMEZymeworks
CELCCelcuity

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Quoin Pharmaceuticals

3 Months
Naz Rahman
Naz RahmanMaxim Group
Success Rate5/30 ratings generated profit
17%
Average Return
-27.61%

Copying Naz Rahman's trades and holding each position for 3 Months would result in 16.67% of your transactions generating a profit, with an average return of -27.61% per trade.

1 Year
Naz Rahman
Naz RahmanMaxim Group
Success Rate2/30 ratings generated profit
7%
Average Return
-60.53%

Copying Naz Rahman's trades and holding each position for 1 Year would result in 6.67% of your transactions generating a profit, with an average return of -60.53% per trade.

2 Years
Naz Rahman
Naz RahmanMaxim Group
Success Rate2/30 ratings generated profit
7%
Average Return
-70.04%

Copying Naz Rahman's trades and holding each position for 2 Years would result in 6.67% of your transactions generating a profit, with an average return of -70.04% per trade.

2EB0 Analyst Recommendation Trends

02468Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for 2EB0
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy64454
Buy00000
Hold00000
Sell00000
Strong Sell00000
total64454

In the current month, 2EB0 has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2EB0 average Analyst price target in the past 3 months is 19.10.

2EB0 Financial Forecast

EUR -8EUR -6EUR -4EUR -2EUR 0Q4 2025Q2 2026Q3 2026
HighEUR -0.86
ConsensusEUR -1.36
LowEUR -1.84

2EB0 Earnings Forecast

Next quarter’s earnings estimate for 2EB0 is -EUR 1.36 with a range of -EUR 1.84 to -EUR 0.86. The previous quarter’s EPS was -EUR 1.70. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

EUR -1EUR -0.5EUR 0EUR 0.5EUR 1Q4 2025Q2 2026Q3 2026
HighEUR 0.00
ConsensusEUR 0.00
LowEUR 0.00

2EB0 Sales Forecast

Next quarter’s sales forecast for 2EB0 is EUR 0 with a range of EUR 0 to EUR 0. The previous quarter’s sales results were EUR 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

2EB0 Stock Forecast FAQ

What is DE:2EB0’s average 12-month price target, according to analysts?
Based on analyst ratings, Quoin Pharmaceuticals’s 12-month average price target is €19.10.
What is DE:2EB0’s upside potential, based on the analysts’ average price target?
Quoin Pharmaceuticals has 394.75% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Quoin Pharmaceuticals a Buy, Sell or Hold?
Quoin Pharmaceuticals has a consensus rating of Strong Buy, which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
What is Quoin Pharmaceuticals’s share price target?
The average share price target for Quoin Pharmaceuticals is €19.10. This is based on 5 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €31.23, and the lowest forecast is €12.49. The average share price target represents a 394.75% increase from the current price of €3.86.
What do analysts say about Quoin Pharmaceuticals?
Quoin Pharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Street analysts.
How can I buy shares of Quoin Pharmaceuticals?
To buy shares of DE:2EB0, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.